Concepedia

Veronika Hrubá

VH

Statistics

Publications

17

Citations

1K

H-Index

14

Active since

2011

Affiliations

Charles University(Current)

Institute of Pharmacology

Iscare I.V.F

Military University Hospital Prague

Czech Academy of Sciences, Institute of Animal Physiology and Genetics

Veronika Hrubá is an author at Charles University specializing in immunology, gastrointestinal inflammation, and inflammatory bowel disease therapy.

Publications per year

2011–2023

17

Publications

17

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24‐week, double‐blind, placebo‐controlled trial

Krzysztof Strojek, Kun‐Ho Yoon, Veronika Hrubá et al. · Diabetes Obesity and Metabolism · 2011 · 413 citations

, , +17

Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation

Dana Ďuricová, Eva Dvořáková, Ondřej Hradský et al. · Inflammatory Bowel Diseases · 2018 · 83 citations

, , +13

Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis

Klaudia Farkas, Mariann Rutka, Petra A. Golovics et al. · Journal of Crohn s and Colitis · 2016 · 81 citations · Full text

, , +14

Dapagliflozin Added to Glimepiride in Patients with Type 2 Diabetes Mellitus Sustains Glycemic Control and Weight Loss Over 48 Weeks: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial

Krzysztof Strojek, Kun‐Ho Yoon, Veronika Hrubá et al. · Diabetes Therapy · 2014 · 72 citations · Full text

, , +17

Twice‐daily dapagliflozin co‐administered with metformin in type 2 diabetes: a 16‐week randomized, placebo‐controlled clinical trial

P.‐M. Schumm‐Draeger, Lesley Burgess, László Korányi et al. · Diabetes Obesity and Metabolism · 2014 · 62 citations

, , +17

1–5 of 17